Two-year-old Evans was brought to the Nyumbani Children’s Home in Nairobi, Kenya a year ago, suffering from HIV and ...
The U.S. government's foreign aid freeze has upended the supply chain for medical products crucial for fighting diseases ...
2don MSN
Florence Makumene held a plastic container of HIV medication and wondered if it would be her last as fears swelled of a ...
Legislation that would remove a criminal penalty for intentionally transferring HIV to another person sailed through both the ...
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
The decline in D.C. HIV cases is a positive trend, but funding cuts could impact future prevention work. Derrick “Strawberry” ...
One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...
The U.N.'s Angeli Achrekar reports that many clinics have closed, despite exemptions in the policy. She fears mortality will ...
The median (IQR) age of the people living with HIV (PLWH) was 49 (38-57) years, with the recently-arrived GBM having a median ...
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
A new HIV drug, lenacapavir, appears highly effective against strains circulating in Uganda, according to a study led by ...
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results